miR-128-3p Reduces Proliferation and Immune Escape in Acute Myeloid Leukemia Through Targeted Regulation of ZEB1
Applied Biochemistry and Biotechnology · 2025
DOI: 10.1007/s12010-025-05255-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, 2025. Verfasst von YanBin Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Peking Union Medical College Hospital, No.1 Shuaifuyuan, Dongcheng District, Beijing City, 100730, China. Hauptthemen laut MEDLINE: MicroRNAs, Zinc Finger E-box-Binding Homeobox 1, Leukemia, Myeloid, Acute, Cell Proliferation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
microRNAs have received wide attention as potential therapeutic targets. This study explored the action of miR-128-3p in acute myeloid leukemia (AML). miR-128-3p expression in AML was determined by quantitative PCR method. MTT proliferation assay and immunoblot assay were employed to detect proteins related to proliferation and apoptosis in THP-1 cells overexpressing miR-128-3p. RNA immunoprecipitation and dual luciferase reporting system were utilized to verify downstream targets of miR-128-3p. Flow cytometry was conducted to analyze the apoptosis rate and immune escape of THP-1 cells in the T-cell co-culture system. miR-128-3p was lowly expressed in AML patients (reduced by 41.6%). Overexpression of miR-128-3p inhibited THP-1 cell proliferation and immune escape, and stimulated apoptosis. ZEB1 was a downstream target of miR-128-3p, and up-regulation of miR-128-3p inhibited ZEB1 mRNA and protein expression (respectively reduced by 65.8% and 42.0%). Upregulating ZEB1 reversed the inhibitory effect of upregulating miR-128-3p on THP-1 cell proliferation and immune escape. Upregulating ZEB1 promoted PD-L1 protein expression (increased by 0.75-fold). Blocking PD-L1 reversed the promotion of THP-1 cell proliferation and immune escape by upregulating ZEB1. The miR-128-3p/ZEB1/PD-L1 axis is involved in regulating the proliferation and immune escape of AML cells, providing new insights into the molecular mechanism of miR-128-3p in AML and, more importantly, a new target for immunotherapy of AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Peking Union Medical College Hospital, No.1 Shuaifuyuan, Dongcheng District, Beijing City, 100730, China.
- Department of Inspection Division, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang City, 441000, Hubei Province, China.
- Department of Hematology, Peking Union Medical College Hospital, No.1 Shuaifuyuan, Dongcheng District, Beijing City, 100730, China. Dr.likuixing@outlook.com.
Zitieren
APA
Zhang, Y., Ma, D., Zhang, X., Chen, W., Wang, X., Sun, R., & Li, K. (2025). miR-128-3p Reduces Proliferation and Immune Escape in Acute Myeloid Leukemia Through Targeted Regulation of ZEB1. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-025-05255-8
Vancouver
Zhang Y, Ma D, Zhang X, Chen W, Wang X, Sun R, et al. miR-128-3p Reduces Proliferation and Immune Escape in Acute Myeloid Leukemia Through Targeted Regulation of ZEB1. Applied Biochemistry and Biotechnology. 2025. doi:10.1007/s12010-025-05255-8
BibTeX
@article{Zhang2025,
author = {Zhang, YanBin and Ma, DanDong and Zhang, XiaoJuan and Chen, WenKun and Wang, XueJiao and Sun, Rui and Li, KuiXing},
title = {miR-128-3p Reduces Proliferation and Immune Escape in Acute Myeloid Leukemia Through Targeted Regulation of ZEB1},
journal = {Applied Biochemistry and Biotechnology},
year = {2025},
doi = {10.1007/s12010-025-05255-8}
}
EUVIMED